Craniopharyngioma natural history, complication and prognosis: Difference between revisions
| Line 23: | Line 23: | ||
==Prognosis== | ==Prognosis== | ||
Since craniopharyngioma is a benign tumor, the 5-year and 10-year survival rates, regardless of treatment given, are higher than '''90%'''. The prognosis is very good.<ref>Prognosis of Craniopharyngioma. Cancer gov. http://www.cancer.gov/types/brain/hp/child-cranio-treatment-pdq#link/_40_toc</ref>. Patients can have a permanent cure if the tumor can be completely removed with surgery or treated with high doses of radiation. If the tumor returns, it will usually come back within the first 2 years after surgery.<ref>Prognosis. National Library of Medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000345.htm</ref> The outlook depends on: | Since craniopharyngioma is a [[benign]] tumor, the 5-year and 10-year survival rates, regardless of treatment given, are higher than '''90%'''. The [[prognosis]] is very good.<ref>Prognosis of Craniopharyngioma. Cancer gov. http://www.cancer.gov/types/brain/hp/child-cranio-treatment-pdq#link/_40_toc</ref>. Patients can have a permanent cure if the tumor can be completely removed with [[surgery]] or treated with high doses of [[radiation]]. If the tumor returns, it will usually come back within the first 2 years after surgery.<ref>Prognosis. National Library of Medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000345.htm</ref> The outlook depends on: | ||
*Whether or not the tumor can be removed by surgery. | *Whether or not the tumor can be removed by surgery. | ||
*The neurological deficits and hormonal imbalances caused by the tumor and the treatment | *The neurological deficits and hormonal imbalances caused by the tumor and the treatment | ||
*The patient’s general health | *The patient’s general health | ||
Recent research<ref name="ReferenceA">{{cite journal|last1=Sofela|first1=AA|last2=Hettige|first2=S|last3=Curran|first3=O|last4=Bassi|first4=S|title=Malignant transformation in craniopharyngiomas.|journal=Neurosurgery|date=Sep 2014|volume=75|issue=3|pages=306–14; discussion 314|pmid=24978859|doi=10.1227/NEU.0000000000000380}}</ref> has demonstrated a malignant (but rare) tendency of craniopharyngiomas. These malignant craniopharyngiomas are very rare, but are associated with ''poor'' prognosis. | Recent research<ref name="ReferenceA">{{cite journal|last1=Sofela|first1=AA|last2=Hettige|first2=S|last3=Curran|first3=O|last4=Bassi|first4=S|title=Malignant transformation in craniopharyngiomas.|journal=Neurosurgery|date=Sep 2014|volume=75|issue=3|pages=306–14; discussion 314|pmid=24978859|doi=10.1227/NEU.0000000000000380}}</ref> has demonstrated a [[malignant]] (but rare) tendency of craniopharyngiomas. These malignant craniopharyngiomas are very rare, but are associated with ''poor'' prognosis. | ||
==References== | ==References== | ||
Revision as of 19:11, 24 August 2015
|
Craniopharyngioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Craniopharyngioma natural history, complication and prognosis On the Web |
|
American Roentgen Ray Society Images of Craniopharyngioma natural history, complication and prognosis |
|
FDA on Craniopharyngioma natural history, complication and prognosis |
|
CDC on Craniopharyngioma natural history, complication and prognosis |
|
Craniopharyngioma natural history, complication and prognosis in the news |
|
Blogs on Craniopharyngioma natural history, complication and prognosis |
|
Risk calculators and risk factors for Craniopharyngioma natural history, complication and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Common complications of craniopharyngioma are long-term hormonal problems, vision defects and nervous system deficits. Since craniopharyngioma is a benign tumor, the 5-year and 10-year survival rates are higher than 90%. Recent research has demonstrated a malignant] (but rare) tendency of craniopharyngiomas. These malignant craniopharyngiomas are very rare, but are associated with poor prognosis.
Natural History
Complications
A large percentage of patients have long-term hormone, vision, and nervous system problems after craniopharyngioma is treated. When the tumor is not completely removed, the condition may recur.[1]
There are complications caused by the radical surgical treatment of craniopharyngioma:[2]
- Obesity, which can be life-threatening. Hypothalamic-sparing surgical techniques may result in reduced postoperative obesity without an increase in tumor recurrence
- Hormone replacement therapy
- Severe behavioral problems
- Blindness
- Seizures
- Spinal fluid leak
- False aneurysms
- Difficulty with eye movements
- Death from intraoperative hemorrhage, hypothalamic damage, or stroke (rare)
Prognosis
Since craniopharyngioma is a benign tumor, the 5-year and 10-year survival rates, regardless of treatment given, are higher than 90%. The prognosis is very good.[3]. Patients can have a permanent cure if the tumor can be completely removed with surgery or treated with high doses of radiation. If the tumor returns, it will usually come back within the first 2 years after surgery.[4] The outlook depends on:
- Whether or not the tumor can be removed by surgery.
- The neurological deficits and hormonal imbalances caused by the tumor and the treatment
- The patient’s general health
Recent research[5] has demonstrated a malignant (but rare) tendency of craniopharyngiomas. These malignant craniopharyngiomas are very rare, but are associated with poor prognosis.
References
- ↑ Complications of Craniopharyngioma. National library of medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000345.htm
- ↑ Complications. Cancer gov. http://www.cancer.gov/types/brain/hp/child-cranio-treatment-pdq#link/_40_toc
- ↑ Prognosis of Craniopharyngioma. Cancer gov. http://www.cancer.gov/types/brain/hp/child-cranio-treatment-pdq#link/_40_toc
- ↑ Prognosis. National Library of Medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000345.htm
- ↑ Sofela, AA; Hettige, S; Curran, O; Bassi, S (Sep 2014). "Malignant transformation in craniopharyngiomas". Neurosurgery. 75 (3): 306–14, discussion 314. doi:10.1227/NEU.0000000000000380. PMID 24978859.